Stryker (SYK) Curent Deferred Tax Liability (2009 - 2010)
Stryker's (SYK) quarterly Curent Deferred Tax Liability came in at $26.9 million in Q4 2010, up 11.62% year-over-year from $24.1 million in Q4 2009, and up 11.62% quarter-over-quarter from $24.1 million in Q4 2009.
Powered by 
Analysis
Stryker (SYK) Curent Deferred Tax Liability (2009 - 2010) Analysis & Trends
Stryker (SYK) has reported Curent Deferred Tax Liability for 2 consecutive years, with $26.9 million the latest figure, recorded in Q4 2010.
- On a quarterly basis, Curent Deferred Tax Liability rose 11.62% year-over-year to $26.9 million in Q4 2010; TTM through Dec 2010 was $26.9 million, a 11.62% increase from a year earlier, with the FY2010 full-year figure at $26.9 million, up 11.62% from the prior year.
- Curent Deferred Tax Liability was $26.9 million for Q4 2010 at Stryker, up from $24.1 million in the prior quarter.
- Over five years, Curent Deferred Tax Liability peaked at $26.9 million in Q4 2010 and troughed at $24.1 million in Q4 2009.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Curent Deferred Tax Liability (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | - |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | - |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | - |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | - |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | - |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | - |
| 10 | Zimmer Biomet Holdings | 18.20 Bn | 17.79 Bn | 1.54 Bn | - |